Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-001767
Filing Date
2025-03-06
Accepted
2025-03-06 13:52:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4481
  Complete submission text file 0001959173-25-001767.txt   5915
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Subject) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36076 | Film No.: 25714600
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Wolchko J Scott (Reporting) CIK: 0001586893 (see all company filings)

Type: 144